Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17524-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17524-1-AP, RRID:AB_2296035
- Product name
- Inhibin beta A-Specific antibody
- Antibody type
- Polyclonal
- Description
- Inhibin beta A-Specific antibody (Cat. #17524-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references INHBA Promotes the Progression of Gastric Cancer by Activating MAPK Signaling Pathway via Targeting ITGA6.
Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.
Amelioration of polycystic ovarian morphology by Tokishakuyakusan in a PCOS rat model: association with bone morphogenetic protein 4.
INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism.
Zhou G, Zhang R, Nie L, Si Y, Liu T, Wang J, Han S, Xuan M, Wang J, Yu W
Oncology research 2026;34(3):25
Oncology research 2026;34(3):25
Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.
Yang CH, Renantha RR, Hsu PC, Wu AT, Wu SY, Azizah N, Ritmaleni R, Chen JH, Lee JC, Fang CY, Lin KC
Journal of dental sciences 2026 Jan;21(1):282-293
Journal of dental sciences 2026 Jan;21(1):282-293
Amelioration of polycystic ovarian morphology by Tokishakuyakusan in a PCOS rat model: association with bone morphogenetic protein 4.
Ueda M, Osuka S, Yabuki A, Miyake N, Fujitsuka N, Nahata M, Tokita Y, Ruan J, Bayasula, Takeda T, Seki T, Sonehara R, Muraoka A, Nakamura T, Kajiyama H
Frontiers in endocrinology 2025;16:1649124
Frontiers in endocrinology 2025;16:1649124
INHBA promotes chemoresistance in pancreatic cancer by enhancing CTPS1 stability and mediating pyrimidine metabolism.
Sun X, Wei Z, Liao X, Zheng D, Li F, Chen L, Gong Y, Ran S, Han X, He Z, Yu C
Cancer cell international 2025 Nov 14;25(1):403
Cancer cell international 2025 Nov 14;25(1):403
No comments: Submit comment
Supportive validation
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- PC-3 cells were subjected to SDS PAGE followed by western blot with 17524-1-AP(INHBA-Specific antibody) at dilution of 1:300
- Sample type
- cell line
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The Inhibin beta A-Specific antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human Inhibin beta A-Specific. This antibody recognizes human,mouse,rat antigen. The Inhibin beta A-Specific antibody has been validated for the following applications: ELISA, WB analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- rat brain tissue were subjected to SDS PAGE followed by western blot with 17524-1-AP(INHBA-Specific antibody) at dilution of 1:300
- Sample type
- tissue